Kaye Edward M. MD

CIK 00015227802 companiesBEDFORD, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001522780

Recent Transactions

36 trades

Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-05$31.15/sh−1,681→ 63,054 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-05$31.33/sh−6,367→ 64,735 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-05$31.85/sh−500→ 62,554 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-05$31.15/sh−1,681→ 63,054 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-05$31.85/sh−500→ 62,554 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-05$31.33/sh−6,367→ 64,735 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-04$31.32/sh−1,231→ 71,102 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-04$30.76/sh−5,222→ 72,333 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-04$31.32/sh−1,231→ 71,102 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-04$30.76/sh−5,222→ 72,333 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-03+26,250→ 77,555 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Performance Stock Units
2025-12-03−26,250→ 0 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-03$30.34/sh−419→ 51,956 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-03$30.34/sh−419→ 51,956 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-03$30.85/sh−651→ 51,305 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-03+26,250→ 77,555 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Performance Stock Units
2025-12-03−26,250→ 0 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-03$30.85/sh−651→ 51,305 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-02$30.14/sh−405→ 52,375 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-02$29.56/sh−661→ 52,780 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-02$30.14/sh−405→ 52,375 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-02$29.56/sh−661→ 52,780 total
Exercise/Conversion
CYTOKINETICS INC$CYTK
Common Stock
2025-12-01$14.25/sh+20,000→ 38,041 total
Exercise/Conversion
CYTOKINETICS INC$CYTK
Common Stock
2025-12-01$12.40/sh+8,064→ 18,041 total
Sale
CYTOKINETICS INC$CYTK
Common Stock
2025-12-01$66.72/sh−28,064→ 9,977 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Restricted Stock Units
2025-12-01−4,317→ 0 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Restricted Stock Units
2025-12-01−4,317→ 0 total
Exercise/Conversion
CYTOKINETICS INC$CYTK
Non-Qualified Stock Option (Right to Buy)
2025-12-01−20,000→ 0 total
Exercise/Conversion
CYTOKINETICS INC$CYTK
Non-Qualified Stock Option (Right to Buy)
2025-12-01−8,064→ 0 total
Sale
CYTOKINETICS INC$CYTK
Common Stock
2025-12-01$66.72/sh−28,064→ 9,977 total
Exercise/Conversion
CYTOKINETICS INC$CYTK
Common Stock
2025-12-01$14.25/sh+20,000→ 38,041 total
Exercise/Conversion
CYTOKINETICS INC$CYTK
Common Stock
2025-12-01$12.40/sh+8,064→ 18,041 total
Exercise/Conversion
CYTOKINETICS INC$CYTK
Non-Qualified Stock Option (Right to Buy)
2025-12-01−20,000→ 0 total
Exercise/Conversion
CYTOKINETICS INC$CYTK
Non-Qualified Stock Option (Right to Buy)
2025-12-01−8,064→ 0 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2024-12-01+4,317→ 53,441 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2024-12-01+4,317→ 53,441 total

Companies

Recent Filings

Address

C/O STOKE THERAPEUTICS, INC. 45 WIGGINS AVENUE

BEDFORD, MA, 01730

View on SEC.gov